Tapewire

Nasdaq · USD

GDRX

GoodRx Holdings, Inc.

Export transactions ↓
Tapewire entity
4838
SEC CIK
0001809519
Parsed reports
334

Last 12 months

Inside the activity.

0 purchase rows · 14 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 2026014
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
March 13, 2025 Filed Mar 14, 2025 21:39 UTC
Wagner ScottDirector
GiftClass A Common Stock 64,232 $0.00 $0.00
Disclosure

SEC source: 0001809519-25-000051 · wk-form4_1741988364.xml · nonDerivative · entry 3

Wagner Scott · CIK 0001342655 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 125,154

F3 · kind: Represents a gift of shares directly held by the Reporting Person to the Avery J. Wagner 2012 Irrevocable Trust for estate planning purposes. Following the transaction, the reporting person has neither investment control over nor a pecuniary interest in the transferred shares.

Read SEC document
March 13, 2025 Filed Mar 14, 2025 21:39 UTC
Wagner ScottDirector
GiftClass A Common Stock 64,232 $0.00 $0.00
Disclosure

SEC source: 0001809519-25-000051 · wk-form4_1741988364.xml · nonDerivative · entry 2

Wagner Scott · CIK 0001342655 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 189,386

F2 · kind: Represents a gift of shares directly held by the Reporting Person to the Drew S. Wagner 2012 Irrevocable Trust for estate planning purposes. Following the transaction, the reporting person has neither investment control over nor a pecuniary interest in the transferred shares.

Read SEC document
March 13, 2025 Filed Mar 14, 2025 21:39 UTC
Wagner ScottDirector
GiftClass A Common Stock 64,232 $0.00 $0.00
Disclosure

SEC source: 0001809519-25-000051 · wk-form4_1741988364.xml · nonDerivative · entry 1

Wagner Scott · CIK 0001342655 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 253,618

F1 · kind: Represents a gift of shares directly held by the Reporting Person to the Charles W. Wagner 2012 Irrevocable Trust for estate planning purposes. Following the transaction, the reporting person has neither investment control over nor a pecuniary interest in the transferred shares.

Read SEC document
March 08, 2025 Filed Mar 10, 2025 17:06 UTC
Nabiey RominChief Accounting Officer
Exercise / conversionRestricted Stock Unit · Derivative 2,233 $0.00 $0.00
Disclosure

SEC source: 0001809519-25-000050 · wk-form4_1741640810.xml · derivative · entry 6

Nabiey Romin · CIK 0001924892 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,787

Underlying: Class A Common Stock · 2,233 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock.

F3 · derivative.exercise_date: The restricted stock unit award will vest as to 6.25% of the underlying shares on June 8, 2024 with the remaining 93.75% vesting in approximately equal quarterly installments thereafter for 15 quarters.

F3 · derivative.expiration_date: The restricted stock unit award will vest as to 6.25% of the underlying shares on June 8, 2024 with the remaining 93.75% vesting in approximately equal quarterly installments thereafter for 15 quarters.

Read SEC document
March 08, 2025 Filed Mar 10, 2025 17:06 UTC
Nabiey RominChief Accounting Officer
Exercise / conversionRestricted Stock Unit · Derivative 10,201 $0.00 $0.00
Disclosure

SEC source: 0001809519-25-000050 · wk-form4_1741640810.xml · derivative · entry 5

Nabiey Romin · CIK 0001924892 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 61,205

Underlying: Class A Common Stock · 10,201 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock.

F2 · derivative.exercise_date: The restricted stock unit award vested as to 6.25% of the underlying shares on December 8, 2022 with the remaining 93.75% vesting in approximately equal quarterly installments thereafter for 15 quarters.

F2 · derivative.expiration_date: The restricted stock unit award vested as to 6.25% of the underlying shares on December 8, 2022 with the remaining 93.75% vesting in approximately equal quarterly installments thereafter for 15 quarters.

Read SEC document
March 08, 2025 Filed Mar 10, 2025 17:06 UTC
Nabiey RominChief Accounting Officer
Tax withholdingClass A Common Stock 808 $4.61 $3,724.88
Disclosure

SEC source: 0001809519-25-000050 · wk-form4_1741640810.xml · nonDerivative · entry 4

Nabiey Romin · CIK 0001924892 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 106,874

Read SEC document
March 08, 2025 Filed Mar 10, 2025 17:06 UTC
Nabiey RominChief Accounting Officer
Exercise / conversionClass A Common Stock 2,233 Not disclosed Not disclosed
Disclosure

SEC source: 0001809519-25-000050 · wk-form4_1741640810.xml · nonDerivative · entry 3

Nabiey Romin · CIK 0001924892 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 107,682

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock.

Read SEC document
March 08, 2025 Filed Mar 10, 2025 17:06 UTC
Nabiey RominChief Accounting Officer
Tax withholdingClass A Common Stock 4,191 $4.61 $19,320.51
Disclosure

SEC source: 0001809519-25-000050 · wk-form4_1741640810.xml · nonDerivative · entry 2

Nabiey Romin · CIK 0001924892 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 105,449

Read SEC document
March 08, 2025 Filed Mar 10, 2025 17:06 UTC
Nabiey RominChief Accounting Officer
Exercise / conversionClass A Common Stock 10,201 Not disclosed Not disclosed
Disclosure

SEC source: 0001809519-25-000050 · wk-form4_1741640810.xml · nonDerivative · entry 1

Nabiey Romin · CIK 0001924892 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 109,640

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock.

Read SEC document
March 05, 2025 Filed Mar 7, 2025 17:11 UTC
Nabiey RominChief Accounting Officer
GrantStock Option (Right to Buy) · Derivative 114,507 $0.00 Strike: $4.94 $0.00
Disclosure

SEC source: 0001809519-25-000048 · wk-form4_1741385459.xml · derivative · entry 3

Nabiey Romin · CIK 0001924892 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 114,507

Underlying: Class A Common Stock · 114,507 shares

Expires 2035-03-05

F3 · derivative.exercise_date: The option will vest and become exercisable as to 6.25% of the underlying shares on May 15, 2025 with the remaining 93.75% underlying shares to vest in approximately equal quarterly installments thereafter for 15 quarters.

Read SEC document
March 05, 2025 Filed Mar 7, 2025 17:11 UTC
Nabiey RominChief Accounting Officer
GrantRestricted Stock Unit · Derivative 76,866 $0.00 $0.00
Disclosure

SEC source: 0001809519-25-000048 · wk-form4_1741385459.xml · derivative · entry 2

Nabiey Romin · CIK 0001924892 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 76,866

Underlying: Class A Common Stock · 76,866 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock.

F2 · derivative.exercise_date: The restricted stock units vest as to 6.25% of the underlying shares on May 15, 2025 and the remaining 93.75% of the underlying shares to vest in approximately equal quarterly installments thereafter for 15 quarters.

F2 · derivative.expiration_date: The restricted stock units vest as to 6.25% of the underlying shares on May 15, 2025 and the remaining 93.75% of the underlying shares to vest in approximately equal quarterly installments thereafter for 15 quarters.

Read SEC document
March 03, 2025 Filed Mar 5, 2025 22:46 UTC
Barnes Wendy LynnDirector · See Remarks
GrantStock Option (Right to Buy) · Derivative 2,828,232 $0.00 Strike: $4.85 $0.00
Disclosure

SEC source: 0001809519-25-000044 · wk-form4_1741214773.xml · derivative · entry 3

Barnes Wendy Lynn · CIK 0002049585 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,828,232

Underlying: Class A Common Stock · 2,828,232 shares

Expires 2035-03-03

F4 · derivative.exercise_date: The option will vest and become exercisable as to 25% of the underlying shares on January 15, 2026 with the remaining 75% underlying shares to vest in approximately equal quarterly installments thereafter for 12 quarters. The option is subject to early exercise and, therefore, all or any part of the option can be exercised at any time. If the reporting person elects to early exercise and purchase shares prior to the vesting of such shares, the shares will be deemed restricted stock and will be subject to a repurchase option in favor of the Issuer if the reporting person's service to the Issuer terminates prior to vesting.

Read SEC document
March 03, 2025 Filed Mar 5, 2025 22:46 UTC
Barnes Wendy LynnDirector · See Remarks
GrantRestricted Stock Unit · Derivative 409,416 $0.00 $0.00
Disclosure

SEC source: 0001809519-25-000044 · wk-form4_1741214773.xml · derivative · entry 2

Barnes Wendy Lynn · CIK 0002049585 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 409,416

Underlying: Class A Common Stock · 409,416 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock.

F3 · derivative.exercise_date: The restricted stock unit award will vest as to 50% of the underlying shares on January 15, 2026 with the remaining 50% underlying shares to vest in approximately equal quarterly installments thereafter for 4 quarters.

F3 · derivative.expiration_date: The restricted stock unit award will vest as to 50% of the underlying shares on January 15, 2026 with the remaining 50% underlying shares to vest in approximately equal quarterly installments thereafter for 4 quarters.

Read SEC document
March 03, 2025 Filed Mar 5, 2025 22:46 UTC
Barnes Wendy LynnDirector · See Remarks
GrantRestricted Stock Unit · Derivative 1,842,374 $0.00 $0.00
Disclosure

SEC source: 0001809519-25-000044 · wk-form4_1741214773.xml · derivative · entry 1

Barnes Wendy Lynn · CIK 0002049585 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,842,374

Underlying: Class A Common Stock · 1,842,374 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock.

F2 · derivative.exercise_date: The restricted stock unit award will vest as to 25% of the underlying shares on January 15, 2026 with the remaining 75% underlying shares to vest in approximately equal quarterly installments thereafter for 12 quarters.

F2 · derivative.expiration_date: The restricted stock unit award will vest as to 25% of the underlying shares on January 15, 2026 with the remaining 75% underlying shares to vest in approximately equal quarterly installments thereafter for 12 quarters.

Read SEC document
March 03, 2025 Filed Mar 5, 2025 22:47 UTC GrantStock Option (Right to Buy) · Derivative 1,096,937 $0.00 Strike: $4.85 $0.00
Disclosure

SEC source: 0001809519-25-000046 · wk-form4_1741214861.xml · derivative · entry 2

McGinnis Christopher A · CIK 0001652479 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,096,937

Underlying: Class A Common Stock · 1,096,937 shares

Expires 2035-03-03

F3 · derivative.exercise_date: The option will vest and become exercisable as to 25% of the underlying shares on February 15, 2026 with the remaining 75% underlying shares to vest in approximately equal quarterly installments thereafter for 12 quarters.

Read SEC document
March 03, 2025 Filed Mar 5, 2025 22:47 UTC GrantRestricted Stock Unit · Derivative 716,479 $0.00 $0.00
Disclosure

SEC source: 0001809519-25-000046 · wk-form4_1741214861.xml · derivative · entry 1

McGinnis Christopher A · CIK 0001652479 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 716,479

Underlying: Class A Common Stock · 716,479 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock.

F2 · derivative.exercise_date: The restricted stock unit award will vest as to 25% of the underlying shares on February 15, 2026 with the remaining 75% underlying shares to vest in approximately equal quarterly installments thereafter for 12 quarters.

F2 · derivative.expiration_date: The restricted stock unit award will vest as to 25% of the underlying shares on February 15, 2026 with the remaining 75% underlying shares to vest in approximately equal quarterly installments thereafter for 12 quarters.

Read SEC document
February 08, 2025 Filed Feb 11, 2025 17:56 UTC
Nabiey RominChief Accounting Officer
Exercise / conversionRestricted Stock Unit · Derivative 12,662 $0.00 $0.00
Disclosure

SEC source: 0001809519-25-000024 · wk-form4_1739314569.xml · derivative · entry 3

Nabiey Romin · CIK 0001924892 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 113,965

Underlying: Class A Common Stock · 12,662 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock.

F2 · derivative.exercise_date: The restricted stock units vest as to 6.25% of the underlying shares on August 8, 2023 and the remaining 93.75% of the underlying shares vest in approximately equal quarterly installments thereafter for 15 quarters.

F2 · derivative.expiration_date: The restricted stock units vest as to 6.25% of the underlying shares on August 8, 2023 and the remaining 93.75% of the underlying shares vest in approximately equal quarterly installments thereafter for 15 quarters.

Read SEC document
February 08, 2025 Filed Feb 11, 2025 17:56 UTC
Nabiey RominChief Accounting Officer
Tax withholdingClass A Common Stock 5,202 $4.84 $25,177.68
Disclosure

SEC source: 0001809519-25-000024 · wk-form4_1739314569.xml · nonDerivative · entry 2

Nabiey Romin · CIK 0001924892 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 99,439

Read SEC document
February 08, 2025 Filed Feb 11, 2025 17:56 UTC
Nabiey RominChief Accounting Officer
Exercise / conversionClass A Common Stock 12,662 Not disclosed Not disclosed
Disclosure

SEC source: 0001809519-25-000024 · wk-form4_1739314569.xml · nonDerivative · entry 1

Nabiey Romin · CIK 0001924892 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 104,641

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock.

Read SEC document
January 21, 2025 Filed Jan 23, 2025 22:15 UTC
Wagner ScottDirector
GrantDeferred Stock Unit · Derivative 94,182 $0.00 $0.00
Disclosure

SEC source: 0001809519-25-000016 · wk-form4_1737670511.xml · derivative · entry 4

Wagner Scott · CIK 0001342655 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 94,182

Underlying: Class A Common Stock · 94,182 shares

Expires not disclosed

F4 · derivative.exercise_price: Each deferred stock unit represents a contingent right to receive one share of Class A common stock.

F5 · derivative.exercise_date: The deferred stock unit award vests as to one-third of the shares underlying the award on each of the first three anniversaries of the grant date, beginning on January 21, 2026, subject to continued service through the applicable vesting date. The deferred stock units will settle on the earliest to occur of the following events (i) December 31, 2030; (ii) Separation from Service; (iii) a Change in Control; (iv) death; or (v) Disability (each, as defined under the GoodRx Holdings, Inc. Deferred Compensation Plan for Directors).

F5 · derivative.expiration_date: The deferred stock unit award vests as to one-third of the shares underlying the award on each of the first three anniversaries of the grant date, beginning on January 21, 2026, subject to continued service through the applicable vesting date. The deferred stock units will settle on the earliest to occur of the following events (i) December 31, 2030; (ii) Separation from Service; (iii) a Change in Control; (iv) death; or (v) Disability (each, as defined under the GoodRx Holdings, Inc. Deferred Compensation Plan for Directors).

Read SEC document
January 21, 2025 Filed Jan 23, 2025 22:15 UTC
Wagner ScottDirector
GrantClass A Common Stock 19,217 $0.00 $0.00
Disclosure

SEC source: 0001809519-25-000016 · wk-form4_1737670511.xml · nonDerivative · entry 2

Wagner Scott · CIK 0001342655 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 317,850

F2 · shares: Reflects deferred stock units. Each deferred stock unit represents a contingent right to receive one share of Class A common stock. The deferred stock units vest in full on the earlier of (i) June 6, 2025 and (ii) the date of the 2025 Annual Meeting of Stockholders, subject to continued service through the applicable vesting date. The deferred stock units will settle on the earliest to occur of the following events (i) December 31, 2030; (ii) Separation from Service; (iii) a Change in Control; (iv) death; or (v) Disability (each, as defined under the GoodRx Holdings, Inc. Deferred Compensation Plan for Directors).

Read SEC document
January 21, 2025 Filed Jan 23, 2025 22:15 UTC
Wagner ScottDirector
GrantClass A Common Stock 9,524 $0.00 $0.00
Disclosure

SEC source: 0001809519-25-000016 · wk-form4_1737670511.xml · nonDerivative · entry 1

Wagner Scott · CIK 0001342655 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 298,633

F1 · shares: Reflects deferred stock units. Each deferred stock unit represents a contingent right to receive one share of Class A common stock. The deferred stock units will vest in substantially equal monthly installments beginning on January 31, 2025 and ending on December 31, 2025, subject to continued service through the applicable vesting date. The deferred stock units will settle on the earliest to occur of the following events (i) December 31, 2030; (ii) Separation from Service; (iii) a Change in Control; (iv) death; or (v) Disability (each, as defined under the GoodRx Holdings, Inc. Deferred Compensation Plan for Directors).

Read SEC document
January 15, 2025 Filed Jan 15, 2025 17:56 UTC
Nabiey RominChief Accounting Officer
Exercise / conversionRestricted Stock Unit · Derivative 2,606 $0.00 $0.00
Disclosure

SEC source: 0001809519-25-000010 · wk-form4_1736981776.xml · derivative · entry 3

Nabiey Romin · CIK 0001924892 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 2,606 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock.

F2 · derivative.exercise_date: The restricted stock units vested 19% on April 15, 2021, and the remaining 81% vested or will vest in equal quarterly installments over the following 15 quarters.

F2 · derivative.expiration_date: The restricted stock units vested 19% on April 15, 2021, and the remaining 81% vested or will vest in equal quarterly installments over the following 15 quarters.

Read SEC document
January 15, 2025 Filed Jan 15, 2025 17:56 UTC
Nabiey RominChief Accounting Officer
Tax withholdingClass A Common Stock 1,071 $4.15 $4,444.65
Disclosure

SEC source: 0001809519-25-000010 · wk-form4_1736981776.xml · nonDerivative · entry 2

Nabiey Romin · CIK 0001924892 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 91,979

Read SEC document
January 15, 2025 Filed Jan 15, 2025 17:56 UTC
Nabiey RominChief Accounting Officer
Exercise / conversionClass A Common Stock 2,606 Not disclosed Not disclosed
Disclosure

SEC source: 0001809519-25-000010 · wk-form4_1736981776.xml · nonDerivative · entry 1

Nabiey Romin · CIK 0001924892 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 93,050

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock.

Read SEC document
January 08, 2025 Filed Jan 8, 2025 18:43 UTC
Voermann KarstenChief Financial Officer
Exercise / conversionRestricted Stock Unit · Derivative 89,292 $0.00 $0.00
Disclosure

SEC source: 0001809519-25-000008 · wk-form4_1736379800.xml · derivative · entry 3

Voermann Karsten · CIK 0001822140 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 267,876

Underlying: Class A Common Stock · 89,292 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock.

F2 · derivative.exercise_date: The restricted stock unit award will vest as to 25% of the underlying shares on January 8, 2025 with the remaining 75% to vest in approximately equal quarterly installments thereafter for 12 quarters.

F2 · derivative.expiration_date: The restricted stock unit award will vest as to 25% of the underlying shares on January 8, 2025 with the remaining 75% to vest in approximately equal quarterly installments thereafter for 12 quarters.

Read SEC document
January 08, 2025 Filed Jan 8, 2025 18:43 UTC
Voermann KarstenChief Financial Officer
Tax withholdingClass A Common Stock 29,035 $4.41 $128,044.35
Disclosure

SEC source: 0001809519-25-000008 · wk-form4_1736379800.xml · nonDerivative · entry 2

Voermann Karsten · CIK 0001822140 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 363,561

Read SEC document
January 08, 2025 Filed Jan 8, 2025 18:43 UTC
Voermann KarstenChief Financial Officer
Exercise / conversionClass A Common Stock 89,292 Not disclosed Not disclosed
Disclosure

SEC source: 0001809519-25-000008 · wk-form4_1736379800.xml · nonDerivative · entry 1

Voermann Karsten · CIK 0001822140 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 392,596

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock.

Read SEC document
January 01, 2025 Filed Jan 4, 2025 00:09 UTC GrantClass A Common Stock 6,392 $0.00 $0.00
Disclosure

SEC source: 0001809519-25-000004 · wk-form4_1735949341.xml · nonDerivative · entry 1

Hirsch Douglas Joseph · CIK 0001822522 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 154,338

F1 · shares: Reflects deferred stock units. Each deferred stock unit represents a contingent right to receive one share of Class A common stock. The deferred stock units will vest in substantially equal monthly installments beginning on January 31, 2025 and ending on December 31, 2025, subject to continued service through the applicable vesting date. The deferred stock units will settle on the earliest to occur of the following events (i) December 31, 2028; (ii) Separation from Service; (iii) a Change in Control; (iv) death; or (v) Disability (each, as defined under the GoodRx Holdings, Inc. Deferred Compensation Plan for Directors).

Read SEC document
January 01, 2025 Filed Jan 4, 2025 00:07 UTC GrantClass A Common Stock 10,653 $0.00 $0.00
Disclosure

SEC source: 0001809519-25-000002 · wk-form4_1735949262.xml · nonDerivative · entry 1

Bruehlman Ronald E · CIK 0001604076 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,284

F1 · shares: Reflects deferred stock units. Each deferred stock unit represents a contingent right to receive one share of Class A common stock. The deferred stock units will vest in substantially equal monthly installments beginning on January 31, 2025 and ending on December 31, 2025, subject to continued service through the applicable vesting date. The deferred stock units will settle on the earliest to occur of the following events (i) December 31, 2030; (ii) Separation from Service; (iii) a Change in Control; (iv) death; or (v) Disability (each, as defined under the GoodRx Holdings, Inc. Deferred Compensation Plan for Directors).

Read SEC document
December 21, 2024 Filed Dec 23, 2024 22:31 UTC Exercise / conversionRestricted Stock Unit · Derivative 23,150 $0.00 $0.00
Disclosure

SEC source: 0001809519-24-000235 · wk-form4_1734993065.xml · derivative · entry 2

Kennedy Kelly J. · CIK 0001545591 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 46,298

Underlying: Class A Common Stock · 23,150 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock.

F2 · derivative.exercise_date: The restricted stock unit award vests as to one-third of the shares underlying the award on each of the first three anniversaries of the grant date, beginning on December 21, 2024, subject to the Reporting Person's continued service with the Issuer through the applicable vesting date.

F2 · derivative.expiration_date: The restricted stock unit award vests as to one-third of the shares underlying the award on each of the first three anniversaries of the grant date, beginning on December 21, 2024, subject to the Reporting Person's continued service with the Issuer through the applicable vesting date.

Read SEC document
December 21, 2024 Filed Dec 23, 2024 22:31 UTC Exercise / conversionClass A Common Stock 23,150 $4.44 $102,786.00
Disclosure

SEC source: 0001809519-24-000235 · wk-form4_1734993065.xml · nonDerivative · entry 1

Kennedy Kelly J. · CIK 0001545591 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 54,012

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 08, 2024 Filed Dec 9, 2024 18:36 UTC
Nabiey RominChief Accounting Officer
Exercise / conversionRestricted Stock Unit · Derivative 2,232 $0.00 $0.00
Disclosure

SEC source: 0001809519-24-000206 · wk-form4_1733787371.xml · derivative · entry 6

Nabiey Romin · CIK 0001924892 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,020

Underlying: Class A Common Stock · 2,232 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock.

F3 · derivative.exercise_date: The restricted stock unit award will vest as to 6.25% of the underlying shares on June 8, 2024 with the remaining 93.75% vesting in approximately equal quarterly installments thereafter for 15 quarters.

F3 · derivative.expiration_date: The restricted stock unit award will vest as to 6.25% of the underlying shares on June 8, 2024 with the remaining 93.75% vesting in approximately equal quarterly installments thereafter for 15 quarters.

Read SEC document
December 08, 2024 Filed Dec 9, 2024 18:36 UTC
Nabiey RominChief Accounting Officer
Exercise / conversionRestricted Stock Unit · Derivative 10,200 $0.00 $0.00
Disclosure

SEC source: 0001809519-24-000206 · wk-form4_1733787371.xml · derivative · entry 5

Nabiey Romin · CIK 0001924892 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 71,406

Underlying: Class A Common Stock · 10,200 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock.

F2 · derivative.exercise_date: The restricted stock unit award vested as to 6.25% of the underlying shares on December 8, 2022 with the remaining 93.75% vesting in approximately equal quarterly installments thereafter for 15 quarters.

F2 · derivative.expiration_date: The restricted stock unit award vested as to 6.25% of the underlying shares on December 8, 2022 with the remaining 93.75% vesting in approximately equal quarterly installments thereafter for 15 quarters.

Read SEC document
December 08, 2024 Filed Dec 9, 2024 18:36 UTC
Nabiey RominChief Accounting Officer
Tax withholdingClass A Common Stock 797 $4.91 $3,913.27
Disclosure

SEC source: 0001809519-24-000206 · wk-form4_1733787371.xml · nonDerivative · entry 4

Nabiey Romin · CIK 0001924892 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 90,444

Read SEC document
December 08, 2024 Filed Dec 9, 2024 18:36 UTC
Nabiey RominChief Accounting Officer
Exercise / conversionClass A Common Stock 2,232 Not disclosed Not disclosed
Disclosure

SEC source: 0001809519-24-000206 · wk-form4_1733787371.xml · nonDerivative · entry 3

Nabiey Romin · CIK 0001924892 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 91,241

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock.

Read SEC document
December 08, 2024 Filed Dec 9, 2024 18:36 UTC
Nabiey RominChief Accounting Officer
Tax withholdingClass A Common Stock 3,640 $4.91 $17,872.40
Disclosure

SEC source: 0001809519-24-000206 · wk-form4_1733787371.xml · nonDerivative · entry 2

Nabiey Romin · CIK 0001924892 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 89,009

Read SEC document
December 08, 2024 Filed Dec 9, 2024 18:36 UTC
Nabiey RominChief Accounting Officer
Exercise / conversionClass A Common Stock 10,200 Not disclosed Not disclosed
Disclosure

SEC source: 0001809519-24-000206 · wk-form4_1733787371.xml · nonDerivative · entry 1

Nabiey Romin · CIK 0001924892 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 92,649

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock.

Read SEC document
December 08, 2024 Filed Dec 9, 2024 18:39 UTC
Voermann KarstenChief Financial Officer
Exercise / conversionRestricted Stock Unit · Derivative 54,064 $0.00 $0.00
Disclosure

SEC source: 0001809519-24-000208 · wk-form4_1733787554.xml · derivative · entry 3

Voermann Karsten · CIK 0001822140 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 378,448

Underlying: Class A Common Stock · 54,064 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock.

F2 · derivative.exercise_date: The restricted stock unit award vested as to 6.25% of the underlying shares on December 8, 2022 with the remaining 93.75% vesting in approximately equal quarterly installments thereafter for 15 quarters.

F2 · derivative.expiration_date: The restricted stock unit award vested as to 6.25% of the underlying shares on December 8, 2022 with the remaining 93.75% vesting in approximately equal quarterly installments thereafter for 15 quarters.

Read SEC document
December 08, 2024 Filed Dec 9, 2024 18:39 UTC
Voermann KarstenChief Financial Officer
Tax withholdingClass A Common Stock 24,659 $4.91 $121,075.69
Disclosure

SEC source: 0001809519-24-000208 · wk-form4_1733787554.xml · nonDerivative · entry 2

Voermann Karsten · CIK 0001822140 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 303,304

Read SEC document
December 08, 2024 Filed Dec 9, 2024 18:39 UTC
Voermann KarstenChief Financial Officer
Exercise / conversionClass A Common Stock 54,064 Not disclosed Not disclosed
Disclosure

SEC source: 0001809519-24-000208 · wk-form4_1733787554.xml · nonDerivative · entry 1

Voermann Karsten · CIK 0001822140 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 327,963

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock.

Read SEC document
December 08, 2024 Filed Dec 9, 2024 23:43 UTC
Wagner ScottSee Remarks
Exercise / conversionRestricted Stock Unit · Derivative 70,591 $0.00 $0.00
Disclosure

SEC source: 0001809519-24-000210 · wk-form4_1733787775.xml · derivative · entry 4

Wagner Scott · CIK 0001342655 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 70,591 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock.

F3 · derivative.exercise_date: The restricted stock unit award will vest in approximately equal monthly installments over eight months beginning on May 8, 2024, subject to the Reporting Person's continued employment through the applicable vesting dates.

F3 · derivative.expiration_date: The restricted stock unit award will vest in approximately equal monthly installments over eight months beginning on May 8, 2024, subject to the Reporting Person's continued employment through the applicable vesting dates.

Read SEC document
December 08, 2024 Filed Dec 9, 2024 23:43 UTC
Wagner ScottSee Remarks
Tax withholdingClass A Common Stock 35,776 $4.91 $175,660.16
Disclosure

SEC source: 0001809519-24-000210 · wk-form4_1733787775.xml · nonDerivative · entry 2

Wagner Scott · CIK 0001342655 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 289,109

Read SEC document
December 08, 2024 Filed Dec 9, 2024 23:43 UTC
Wagner ScottSee Remarks
Exercise / conversionClass A Common Stock 70,591 Not disclosed Not disclosed
Disclosure

SEC source: 0001809519-24-000210 · wk-form4_1733787775.xml · nonDerivative · entry 1

Wagner Scott · CIK 0001342655 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 324,885

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock.

Read SEC document
November 08, 2024 Filed Nov 12, 2024 17:36 UTC
Nabiey RominChief Accounting Officer
Exercise / conversionRestricted Stock Unit · Derivative 12,663 $0.00 $0.00
Disclosure

SEC source: 0001809519-24-000198 · wk-form4_1731450988.xml · derivative · entry 3

Nabiey Romin · CIK 0001924892 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 126,627

Underlying: Class A Common Stock · 12,663 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock.

F2 · derivative.exercise_date: The restricted stock units vest as to 6.25% of the underlying shares on August 8, 2023 and the remaining 93.75% of the underlying shares vest in approximately equal quarterly installments thereafter for 15 quarters.

F2 · derivative.expiration_date: The restricted stock units vest as to 6.25% of the underlying shares on August 8, 2023 and the remaining 93.75% of the underlying shares vest in approximately equal quarterly installments thereafter for 15 quarters.

Read SEC document
November 08, 2024 Filed Nov 12, 2024 17:36 UTC
Nabiey RominChief Accounting Officer
Tax withholdingClass A Common Stock 4,519 $5.04 $22,775.76
Disclosure

SEC source: 0001809519-24-000198 · wk-form4_1731450988.xml · nonDerivative · entry 2

Nabiey Romin · CIK 0001924892 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 82,449

Read SEC document
November 08, 2024 Filed Nov 12, 2024 17:36 UTC
Nabiey RominChief Accounting Officer
Exercise / conversionClass A Common Stock 12,663 Not disclosed Not disclosed
Disclosure

SEC source: 0001809519-24-000198 · wk-form4_1731450988.xml · nonDerivative · entry 1

Nabiey Romin · CIK 0001924892 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 86,968

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock.

Read SEC document
November 08, 2024 Filed Nov 12, 2024 22:39 UTC GrantDeferred Stock Unit · Derivative 65,075 $0.00 $0.00
Disclosure

SEC source: 0001809519-24-000202 · wk-form4_1731451158.xml · derivative · entry 3

Bruehlman Ronald E · CIK 0001604076 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 65,075

Underlying: Class A Common Stock · 65,075 shares

Expires not disclosed

F3 · derivative.exercise_price: Each deferred stock unit represents a contingent right to receive one share of Class A common stock.

F4 · derivative.exercise_date: The deferred stock unit award vests as to one-third of the shares underlying the award on each of the first three anniversaries of the grant date, beginning on November 8, 2025, subject to continued service through the applicable vesting date. The deferred stock units will settle on the earliest to occur of the following events (i) December 31, 2029; (ii) Separation from Service; (iii) a Change in Control; (iv) death; or (v) Disability (each, as defined under the GoodRx Holdings, Inc. Deferred Compensation Plan for Directors).

F4 · derivative.expiration_date: The deferred stock unit award vests as to one-third of the shares underlying the award on each of the first three anniversaries of the grant date, beginning on November 8, 2025, subject to continued service through the applicable vesting date. The deferred stock units will settle on the earliest to occur of the following events (i) December 31, 2029; (ii) Separation from Service; (iii) a Change in Control; (iv) death; or (v) Disability (each, as defined under the GoodRx Holdings, Inc. Deferred Compensation Plan for Directors).

Read SEC document
November 08, 2024 Filed Nov 12, 2024 22:39 UTC GrantClass A Common Stock 20,503 $0.00 $0.00
Disclosure

SEC source: 0001809519-24-000202 · wk-form4_1731451158.xml · nonDerivative · entry 2

Bruehlman Ronald E · CIK 0001604076 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,631

F2 · balance_after: Reflects deferred stock units. Each restricted stock unit represents a contingent right to receive one share of Class A common stock. The restricted stock units vest in full on the earlier of (i) June 6, 2025 and (ii) the date of the 2025 Annual Meeting of Stockholders, subject to continued service through the applicable vesting date. The deferred stock units will settle on the earliest to occur of the following events (i) December 31, 2029; (ii) Separation from Service; (iii) a Change in Control; (iv) death; or (v) Disability (each, as defined under the GoodRx Holdings, Inc. Deferred Compensation Plan for Directors).

Read SEC document
November 08, 2024 Filed Nov 12, 2024 22:39 UTC GrantClass A Common Stock 1,128 $0.00 $0.00
Disclosure

SEC source: 0001809519-24-000202 · wk-form4_1731451158.xml · nonDerivative · entry 1

Bruehlman Ronald E · CIK 0001604076 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,128

F1 · balance_after: Reflects deferred stock units. Each deferred stock unit represents a contingent right to receive one share of Class A common stock. The deferred stock units will vest in substantially equal monthly installments on the last calendar day for each remaining month of the 2024 calendar year, beginning on November 30, 2024, subject to continued service through the applicable vesting date. The deferred stock units will settle on the earliest to occur of the following events (i) December 31, 2029; (ii) Separation from Service; (iii) a Change in Control; (iv) death; or (v) Disability (each, as defined under the GoodRx Holdings, Inc. Deferred Compensation Plan for Directors).

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.